by admin | Dec 30, 2022 | News & Opinions
By Heidi Ledford – Nature ‘Most complicated therapy ever’ tailors bespoke, genome-edited immune cells to attack tumours. A small clinical trial has shown that researchers can use CRISPR gene editing to alter immune cells so that they will recognize mutated...
by admin | Dec 29, 2022 | News & Opinions
By Noah Fromson – University of Michigan Health Image caption: Human neural stem cell transplants (green) survive and migrate throughout the mouse brain (blue) when given a novel monoclonal antibody treatment. Michigan Medicine Using antibodies instead of...
by admin | Dec 29, 2022 | News & Opinions
By Susan Murphy – Mayo Clinic Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) — a type of immunotherapy that reprograms a patient’s T cells to recognize and destroy cancer cells — has revolutionized the treatment of blood cancers. While the...
by admin | Dec 28, 2022 | News & Opinions
By Anna MacDonald and Sarah Whelan – Technology Networks Cell and gene therapy is a field of personalized medicine, driving the innovation of medicine and revolutionizing the way we treat disease. Gene therapies use DNA or other genetic material to edit a...
by admin | Dec 27, 2022 | News & Opinions
by Margarida Maia, PhD – Parkinson’s News Today A request to launch a first Phase 1/2 clinical trial of a stem cell-based therapy in people with Parkinson’s disease has been approved by the Swedish Medical Products Agency. The therapy, called STEM-PD,...
